Skip to main content
. 2006 Apr 19;2006(2):CD005321. doi: 10.1002/14651858.CD005321.pub2

Comparison 26. (Hylan G‐F 20 + physiotherapy) versus physiotherapy.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Lequesne Index (0‐24) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 End of treatment 1 21 Mean Difference (IV, Fixed, 95% CI) ‐0.70 [‐3.25, 1.85]
1.2 5 to 13 weeks post‐injection 1 21 Mean Difference (IV, Fixed, 95% CI) ‐0.80 [‐3.95, 2.35]
2 Safety: total withdrawls overall 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
2.1 5 to 13 weeks post‐injection 1 30 Risk Ratio (M‐H, Fixed, 95% CI) 0.5 [0.15, 1.64]
3 Safety: number of patients with adverse events 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
3.1 End of treatment 1 21 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]